Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn's Disease …
A Blondeaux, C Valibouze, S Speca… - International Journal of …, 2024 - mdpi.com
The therapeutic management of Crohn's disease (CD), a chronic relapsing–remitting
inflammatory bowel disease (IBD), is highly challenging. Surgical resection is sometimes a …
inflammatory bowel disease (IBD), is highly challenging. Surgical resection is sometimes a …
[引用][C] Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn's Disease …
A Blondeaux, C Valibouze, S Speca, C Rousseaux… - 2024 - lilloa.univ-lille.fr
Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and
Ileocecal Resection Surgery: Implications for Crohn's Disease Management. Toggle …
Ileocecal Resection Surgery: Implications for Crohn's Disease Management. Toggle …
Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn's Disease …
A Blondeaux, C Valibouze, S Speca… - International …, 2024 - search.ebscohost.com
The therapeutic management of Crohn's disease (CD), a chronic relapsing–remitting
inflammatory bowel disease (IBD), is highly challenging. Surgical resection is sometimes a …
inflammatory bowel disease (IBD), is highly challenging. Surgical resection is sometimes a …
Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn's Disease …
A Blondeaux, C Valibouze, S Speca… - … Journal of Molecular …, 2024 - europepmc.org
The therapeutic management of Crohn's disease (CD), a chronic relapsing–remitting
inflammatory bowel disease (IBD), is highly challenging. Surgical resection is sometimes a …
inflammatory bowel disease (IBD), is highly challenging. Surgical resection is sometimes a …
Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn's Disease …
A Blondeaux, C Valibouze, S Speca… - International …, 2024 - pubmed.ncbi.nlm.nih.gov
The therapeutic management of Crohn's disease (CD), a chronic relapsing-remitting
inflammatory bowel disease (IBD), is highly challenging. Surgical resection is sometimes a …
inflammatory bowel disease (IBD), is highly challenging. Surgical resection is sometimes a …
[HTML][HTML] Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn's Disease …
A Blondeaux, C Valibouze, S Speca… - … Journal of Molecular …, 2024 - ncbi.nlm.nih.gov
The therapeutic management of Crohn's disease (CD), a chronic relapsing–remitting
inflammatory bowel disease (IBD), is highly challenging. Surgical resection is sometimes a …
inflammatory bowel disease (IBD), is highly challenging. Surgical resection is sometimes a …
Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn's Disease …
A Blondeaux, C Valibouze, S Speca… - … Journal of Molecular …, 2024 - europepmc.org
The therapeutic management of Crohn's disease (CD), a chronic relapsing-remitting
inflammatory bowel disease (IBD), is highly challenging. Surgical resection is sometimes a …
inflammatory bowel disease (IBD), is highly challenging. Surgical resection is sometimes a …